Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

ARP2/3 complex is required for directional migration of neural stem cell-derived oligodendrocyte precursors in electric fields.
Pure sensory Guillain-Barré syndrome: A case report and review of the literature.
Cognition and eye movements: assessment of cerebral dysfunction.
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.
Fluctuations of MS births and UV-light exposure.
Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
[White matter lesions, young age, female - differential diagnosis of multiple sclerosis and juvenile stroke].
Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
The organization of the sphingosine 1-phosphate signaling system.
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.
Early accurate diagnosis crucial in multiple sclerosis.
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Exome sequencing to find rare variants causing neurologic diseases.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Accelerometry as a measure of walking behavior in multiple sclerosis.
Lipid domains control myelin basic protein adsorption and membrane interactions between model myelin lipid bilayers.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Alemtuzumab and multiple sclerosis: Is it safe?
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Update on multiple sclerosis treatments.

Pages